Related Experiment Video
Updated: May 31, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides
1Division of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Box 102359, Hanes House, Durham, NC 27710, USA. luke.chen@duke.edu
Abstract:
This article reviews three classes of antibacterial agents that are uncommonly used in bacterial infections and therefore can be thought of as special-use agents. The polymyxins are reserved for gram-negative bacilli that are resistant to virtually all other classes of drugs. Rifampin is used therapeutically, occasionally as a companion drug in treatment of refractory gram-positive coccal infections, especially those involving foreign bodies. Rifaximin is a new rifamycin that is a strict enteric antibiotic approved for treatment of traveler's diarrhea and is showing promise as a possible agent for refractory Clostridium difficile infections. The aminoglycosides are used mainly as companion drugs for the treatment of resistant gram-negative bacillary infections and for gram-positive coccal endocarditis.
Insights
This review covers special-use antibacterial agents: polymyxins for resistant gram-negative infections, rifampin for refractory gram-positive infections, rifaximin for enteric conditions, and aminoglycosides for resistant gram-negative and gram-positive coccal infections.
Area of Science:
- Pharmacology
- Infectious Diseases
- Microbiology
Background:
- Antibiotic resistance necessitates exploration of less common antibacterial agents.
- Special-use antibiotics are crucial for treating infections resistant to standard therapies.
Purpose of the Study:
- To review the therapeutic applications of polymyxins, rifampin, rifaximin, and aminoglycosides.
- To highlight the roles of these agents in managing challenging bacterial infections.
Main Methods:
- Literature review of clinical studies and guidelines.
- Analysis of the mechanisms of action and resistance patterns.
Main Results:
- Polymyxins are reserved for multidrug-resistant Gram-negative bacilli.
- Rifampin and rifaximin show efficacy in specific Gram-positive and enteric infections, respectively.
- Aminoglycosides are valuable adjuncts for resistant Gram-negative and certain Gram-positive infections.
Conclusions:
- Special-use antibiotics like polymyxins, rifampin, rifaximin, and aminoglycosides play vital roles in combating resistant bacterial infections.
- Judicious use of these agents is essential for optimizing patient outcomes.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Chemical Agents for Microbial Control
Antibiotic Selection
Clinical Significance of Antibiotic Resistance

